Osteomyelitis & the Diabetic Foot

Quick Answer

Osteomyelitis is bone infection. Nuclear-medicine work-up depends on the setting: a three-phase bone scan is sensitive but nonspecific; labeled-WBC scintigraphy paired with a sulfur-colloid marrow scan is the specific test for complex/violated bone (diabetic foot, prosthesis) — using the incongruence rule (WBC-positive/marrow-negative = infection); and FDG-PET/CT excels for spondylodiscitis and chronic infection. In the diabetic foot, the central challenge is distinguishing osteomyelitis from Charcot neuroarthropathy, where the WBC+marrow pairing and MRI correlation are decisive.

Definition

Osteomyelitis is infection of bone and marrow, classified as acute vs chronic and by route: hematogenous (children — metaphyseal; adults — vertebral) or contiguous (from an adjacent ulcer/soft-tissue infection or surgery — the diabetic-foot mechanism). Charcot neuroarthropathy is a non-infectious, destructive neuropathic process that mimics osteomyelitis.

Synonyms

Bone infection; acute/chronic osteomyelitis; diabetic-foot osteomyelitis; spondylodiscitis (vertebral osteomyelitis/discitis); septic arthritis (joint).

Epidemiology

Diabetic-foot infection is common and a leading cause of lower-extremity amputation. Hematogenous osteomyelitis affects children (long-bone metaphysis) and older adults (spine). Prosthetic-joint and post-surgical osteomyelitis are important contiguous forms.

Etiology & Risk Factors

• Staphylococcus aureus is the commonest pathogen; diabetic-foot infections are frequently polymicrobial.
• Risk factors: diabetes/neuropathy/peripheral arterial disease, ulceration, trauma/surgery, prosthetic hardware, immunosuppression, and, for vertebral disease, bacteremia/IV drug use.

Pathophysiology

Infection incites an inflammatory and reactive-bone response — increased flow, blood-pool, and osteoblastic activity (positive on all three phases of a bone scan) — with neutrophil migration to the focus (the labeled-WBC target). Charcot produces intense reactive/reparative bone turnover without infection, which is why bone scans and even WBC uptake can be positive; the discriminating step is the marrow (sulfur-colloid) comparison.

Clinical Presentation

Localized pain, swelling, warmth, and a non-healing ulcer; a positive probe-to-bone test raises suspicion in the diabetic foot. Systemic signs may be blunted in diabetes. Vertebral osteomyelitis presents with back pain and fever.

Laboratory Findings

Elevated ESR/CRP and WBC (variable), positive blood/bone cultures; probe-to-bone and bone biopsy/culture where feasible. Poor glycemic control and vascular insufficiency modify presentation.

Imaging Findings by Modality

• Radiographs: insensitive early (changes lag ~2 weeks); useful for chronicity/Charcot deformity.
• MRI (first-line anatomic): marrow edema, cortical destruction, soft-tissue/abscess — high sensitivity; Charcot vs osteomyelitis can still be hard.
• Three-phase bone scan (MDP): sensitive; positive on all three phases in osteomyelitis (vs cellulitis positive on flow/blood-pool only) — but nonspecific in violated bone.
• Labeled-WBC ± sulfur-colloid marrow (SPECT/CT): the specific test for complex bone/prosthesis/diabetic foot — incongruent uptake = infection.
• FDG-PET/CT: high value for spondylodiscitis and chronic osteomyelitis; emerging in the diabetic foot.

Radiopharmaceutical Uptake Mechanisms

MDP marks the osteoblastic/vascular reaction (sensitive, not specific). Labeled leukocytes migrate to neutrophilic infection, but normal/reactive marrow also takes them up — hence the paired sulfur-colloid marrow scan. FDG reflects activated inflammatory-cell glucose metabolism (whole-body, high sensitivity, useful in spine/chronic disease).

Typical Tracers

The Charcot vs Osteomyelitis Problem

In the diabetic foot, the pivotal distinction is osteomyelitis vs Charcot neuroarthropathy:

• Distribution: osteomyelitis usually contiguous to an ulcer (forefoot/pressure points); Charcot classically midfoot with deformity.
• WBC + marrow: incongruent (WBC-positive / marrow-negative) favors infection; congruent favors marrow/Charcot.
• MRI + clinical (ulcer, probe-to-bone, sinus tract) integrate the picture.

Therapy Indications

• Antibiotics (culture-directed, often prolonged) ± surgical debridement; revascularization and offloading in the diabetic foot; amputation for uncontrolled infection.
• Hardware management in prosthetic-joint infection.

Theranostics

None — nuclear medicine's role is diagnosis and localization (particularly the infection-vs-Charcot/marrow distinction and spinal disease).

Differential Diagnosis

• Charcot neuroarthropathy (the key diabetic-foot mimic), soft-tissue infection/cellulitis (no bone involvement), healing fracture/surgery, reactive marrow, and gout.

Reporting Checklist

• For diabetic foot/prosthesis, interpret WBC against the marrow scan (congruent = marrow/Charcot; incongruent = infection).
• Correlate with MRI and clinical (ulcer, probe-to-bone).
• For three-phase scans, state all-three-phase positivity vs blood-pool-only.
• Use FDG for spondylodiscitis/chronic disease.

Prognosis

Depends on infection control, vascular status, and glycemic control; diabetic-foot osteomyelitis carries substantial amputation risk. Accurate infection-vs-Charcot distinction avoids both unnecessary amputation and missed infection.

Board Pearls

A three-phase bone scan is sensitive but nonspecific (osteomyelitis is positive on all three phases; cellulitis on flow/blood-pool only). For complex/violated bone (diabetic foot, prosthesis), the specific test is labeled WBC paired with a sulfur-colloid marrow scan — incongruent (WBC-positive/marrow-negative) = infection; congruent = marrow.

In the diabetic foot, the central question is osteomyelitis vs Charcot neuroarthropathy — Charcot is classically midfoot with deformity and shows congruent WBC/marrow uptake, whereas infection is usually contiguous to an ulcer with incongruent uptake. MRI is the first-line anatomic test.

FDG-PET/CT is the workhorse for spondylodiscitis and chronic osteomyelitis (whole-body, high sensitivity). HMPAO-WBC gives better images/lower dose than In-111 but has bowel/urinary excretion; In-111-WBC is cleaner for the abdomen and allows 24-h delayed imaging.

Related Pages

• Related: Infection & inflammation (strategy selection), bone scintigraphy, Tc-99m-sulfur colloid (marrow imaging).
• Pitfalls: Pearls, pitfalls & normal variants.

Figure / Diagram Suggestions

• A WBC + marrow congruence/incongruence decision plate (infection vs Charcot/marrow).
• An osteomyelitis vs Charcot distribution map (forefoot ulcer vs midfoot deformity).
• A three-phase osteomyelitis-vs-cellulitis schematic.

Common Pitfalls

• Interpreting labeled-WBC uptake alone as infection in violated bone — reactive marrow and Charcot take up leukocytes, so a paired marrow (sulfur-colloid) scan is mandatory before calling osteomyelitis.
• Spatial mismatch between separately acquired WBC and marrow images can create artifactual "incongruence" — co-register (SPECT/CT) and compare identical planes.
• A three-phase bone scan is nonspecific in violated bone — recent fracture, surgery, neuropathic joint, and Charcot are all positive on all three phases and cannot be called infection.
• False-negative WBC studies occur in chronic, walled-off, or low-grade infection (few migrating neutrophils) and in small foot foci lost on planar imaging — add SPECT/CT.
• FDG false positives from Charcot, recent surgery, and neuropathic remodeling, plus reduced FDG sensitivity with hyperglycemia, complicate the diabetic foot.

Self-Check (Board-Style)